Megalencephaly Polymicrogyria Polydactyly Hydrocephalus (MPPH): A Case Report and Review of Literature.
-polycatylyia
hydrocephalo
megalencephaly
polygiria
polymicrogyria
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
accepted:
02
07
2021
entrez:
6
8
2021
pubmed:
7
8
2021
medline:
7
8
2021
Statut:
epublish
Résumé
Megacephaly polymicrogyria, polydactyly, hydrocephalus (MPPH) is an extremely rare condition caused by a defect in the AKT3, CCND2, or PIKR2 genes. Although the prevalence of the syndrome is very low, there is a significant clinical and radiological variation in the syndrome. We present a case with MPPH admitted to the hospital due to an increase in seizure frequency. The patient had a history of cerebral palsy, global developmental delay, spasticity, and hypoglycemic episodes. MRI findings revealed ventriculomegaly, polymicrogyria, abnormal encephalon, and pachygyria. The addition of clobazam and alprazolam diminished the seizures' frequency and the patient's spasticity, respectively. To highlight the clinical and radiological variation of the syndrome, we review cases of MPPH with clinical and radiological variants. Pachygyria and cerebral palsy are new associations not previously described before in MPPH. Pachygyria and cerebral palsy could be worsening the seizures and the global delay in this patient. Hypoglycemic episodes are probably related to the AKT3 gene, promoting more glucose consumption. Spasticity is most probably related to an upper motor sign due to the patient's cerebral palsy. This case highlights the clinical and radiological variation of the syndrome. More cases of MPPH need to be described to consolidate the knowledge and have a better understanding of the clinical and radiological variation of the syndrome.
Identifiants
pubmed: 34354878
doi: 10.7759/cureus.16132
pmc: PMC8327302
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e16132Informations de copyright
Copyright © 2021, Ortiz et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Mol Genet Metab. 2015 Mar;114(3):467-73
pubmed: 25523067
Medicine (Baltimore). 2017 Jun;96(26):e6814
pubmed: 28658095
Mol Genet Genomic Med. 2019 Jun;7(6):e708
pubmed: 31056854
J Child Neurol. 2008 Aug;23(8):916-8
pubmed: 18474936
Neuropediatrics. 2004 Dec;35(6):353-9
pubmed: 15627943
J Clin Exp Dent. 2017 May 1;9(5):e726-e728
pubmed: 28512554
Dev Dyn. 2011 May;240(5):931-42
pubmed: 21445961
J Med Genet. 2005 May;42(5):369-78
pubmed: 15863665
Front Neurol. 2021 Mar 19;12:650653
pubmed: 33815261
Genet Couns. 2015;26(4):381-5
pubmed: 26852507
Pediatr Neurol. 2011 May;44(5):370-3
pubmed: 21481746
Exp Mol Pathol. 2020 Aug;115:104471
pubmed: 32446860
Pediatr Int. 2020 Jan;62(1):115-117
pubmed: 31957131
Am J Med Genet A. 2021 May;185(5):1614-1618
pubmed: 33634562